Pfizer Celebrex Continued Marketing Supported By FDA Cmte.

Committee finds celecoxib has cardiovascular side effects but may be safer than some other COX-2 inhibitors. Cardiovascular events may occur only at higher doses used for non-arthritis patients, some committee members suggest.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet